METACARTIN solution for injection
Back to ProductsPrescription drug. Amino acids and their derivatives. Levocarnitine.
Articles
- All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024″
- Application of the infusion form of L-carnitine in the complex treatment of patients with stage III chronic kidney disease Published in the journal «Medical Business» № 1-2’2018
- Mitochondrial dysfunction in neurodegenerative disorders: from pathogenesis to therapy Published in a journal «International Journal of Neurology» Vol 16 № 4’2020
- Aspects of the use of metabolic therapy in patients with cognitive impairment in post-COVID syndrome Published in the medical newspaper «Health of Ukraine 21st century» № 18 (511)’2021
- Based on the neuro-COVID trilogy Published in the medical newspaper «Health of Ukraine of the 21st century» № 22 (515)’2021
- The role of carnitine in the regulation of energy metabolism and modulation of the course of cardiovascular diseases and diabetes mellitus Published in a journal «Hypertension» Vol 13 № 2 ’2020
- Preventing heart failure and improving prognosis in patients after primary transcutaneous angioplasty by adding L-carnitine in acute myocardial infarction Published in the journal «Cardiology: from science to practice» № 3 (37) ’2019
- Effect of L-carnitine on the lipid profile of patients with coronary artery disease Published in thematic issue «Cardiology, Rheumatology, Cardiac Surgery» № 1 (50) ’2017
- Correction of secondary carnitine deficiency in chronic hemodialysis patients: focus on levocarnitine Published in the journal «Kidneys» № 1 (19) ’2017
SPC
METACARTIN solution for injection
SPC — PDF